New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
09:12 EDTUAL, VRNT, STXS, MDR, HSP, DRTX, CLNE, MDCO, MRVL, ISRG, NVDA, RBCN, ARTXOn The Fly: Pre-market Movers
HIGHER: Intuitive Surgical (ISRG), up 10% after announcing FDA clearance for new da Vinci Xi Surgical System... Clean Energy (CLNE), up 4% after beginning fueling at two stations, signing agreements... Durata Therapeutics (DRTX), up 8% after an FDA Committee voted in favor of its Dalvance injection for the treatment of certain acute bacterial skin and skin structure infections... Rubicon (RBCN), up 7.9% following upgrade at JPMorgan... United Continental (UAL), up 2.2% following upgrade at UBS... NVIDIA (NVDA), up 3% after upgrade at JMP Securities... Marvell (MRVL), up 4% after announcing it plans to appeal patent decision against it... Stereotaxis (STXS), up 12% after submitting 510 Premarket Notification with the FDA for the Vdrive Robotic system... Verint Systems (VRNT), up 5% after reporting earnings that beat expectations and providing a fiscal year outlook that also topped estimates. LOWER: Arotech (ARTX), down 11% after reporting fiscal year earnings and revenue that disappointed... The Medicines Company (MDCO), down 16% after court ruled the company failed to prove that Hospira's (HSP) generic Angiomax product infringed its patents... McDermott (MDR), down 5.8% after filing to sell 10M tangible equity units and saying that its first quarter results may differ "substantially" from the company's expectation.
News For UAL;RBCN;NVDA;ISRG;MRVL;MDCO;CLNE;DRTX;HSP;MDR;STXS;VRNT;ARTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 10, 2014
13:34 EDTRBCNRubicon Technology volatility increases on sharp rally
Rubicon Technology October call option implied volatility is at 148, November is at 181, December is at 206; compared to its 26-week average of 60 according to Track Data, suggesting large near term price movement.
13:23 EDTRBCNRubicon halted for volatility after jumping 34% to $5.39
Subscribe for More Information
10:09 EDTMRVLMarvell management to meet with JPMorgan
Subscribe for More Information
10:01 EDTMDROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 2U (TWOU) initiated with an Outperform at Pacific Crest... Bloomin' Brands (BLMN) initiated with an Outperform at BMO Capital... Brinker (EAT) initiated with a Market Perform at BMO Capital... Buffalo Wild Wings (BWLD) initiated with an Outperform at BMO Capital... Chipotle (CMG) initiated with a Market Perform at BMO Capital... Chuy's (CHUY) initiated with a Market Perform at BMO Capital... Darden (DRI) initiated with a Market Perform at BMO Capital... EMC (EMC) initiated with a Buy at Jefferies... EPR Properties (EPR) initiated with a Buy at BofA/Merrill... HP (HPQ) initiated with a Hold at Jefferies... IBM (IBM) initiated with an Underperform at Jefferies... McDermott (MDR) initiated with an In-Line at Imperial Capital... NetApp (NTAP) initiated with a Hold at Jefferies... New Residential (NRZ) initiated with a Neutral at Piper Jaffray... Nimble Storage (NMBL) initiated with a Buy at Jefferies... Noodles & Company (NDLS) initiated with an Outperform at BMO Capital... PDC Energy (PDCE) initiated with an Overweight at Stephens... Panera Bread (PNRA) initiated with a Market Perform at BMO Capital... Pioneer Natural (PXD) initiated with an Outperform at Imperial Capital... Resource America (REXI) initiated with a Buy at MLV & Co.... Rex Energy (REXX) initiated with an Overweight at Stephens... Seagate (STX) initiated with a Buy at Jefferies... Silicon Motion (SIMO) initiated with a Buy at Brean Capital... Texas Roadhouse (TXRH) initiated with a Market Perform at BMO Capital... W.P. Carey (WPC) initiated with a Neutral at BofA/Merrill... Wayfair (W) initiated with a Buy at Janney Capital...Western Digital (WDC) initiated with a Buy at Jefferies... Yelp (YELP) initiated with a Buy at Sterne Agee.
07:14 EDTMDCOThe Medicines Co's Q3 Angiomax estimate lowered at Credit Suisse
Subscribe for More Information
05:57 EDTMDRStocks with implied volatility movement; RSH MDR
Stocks with implied volatility movement; RadioShack (RSH) 245, McDermott (MDR) 76 according to iVolatility.
05:28 EDTMDRMcDermott initiated with an In-Line at Imperial Capital
Target $5.
October 9, 2014
17:30 EDTUALUnited Continental shares could climb 30%, Barron's says
United Continental shares could trade 30% higher in a year, driven by industry momentum, Barron's argues in its 'Ahead of the Crowd' column. Reference Link
16:57 EDTMDCOThe Medicines Co. announces journal publication of SOLO II phase 3 trial
The Medicines Company announced the publication of the results from the SOLO II phase 3 clinical trial of ORBACTIV, or oritavancin, for injection in the journal Clinical Infectious Diseases. ORBACTIV, is the first and only single dose intravenous antibiotic approved by FDA for the treatment of adults with Acute Bacterial Skin and Skin Structure Infections, or ABSSSI, caused or suspected to be caused by susceptible isolates of designated Gram-positive pathogens. The publication reported that a single, once only, 1200 mg intravenous dose of ORBACTIVTM was non-inferior to twice-daily intravenous dosing of vancomycin given for 7 to 10 days in patients with ABSSSI caused or suspected to be caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. A single 1200 mg IV dose of ORBACTIV results in efficacy in ABSSSIs that is comparable and statistically non-inferior to vancomycin administered intravenously for 7-10 days. ORBACTIV had a safety profile comparable to vancomycin when monitored for up to 60 days following a single dose, with similar intensity, onset and duration of AEs.
09:20 EDTUALOn The Fly: Pre-market Movers
Subscribe for More Information
07:52 EDTUALUnited Continental price target raised to $58 from $53 at UBS
UBS raised its price target on United Continental to $58 from $53 following guidance from the company. The firm expects the stock to trade higher on the update and reiterates its Buy rating on United Continental shares.
07:51 EDTUALUnited Continental lowers Q3 capex view to $470M-$490M, maintains FY view
United Continental expects between $470M-$490M of gross capital expenditures in Q3, which is below previous guidance. The difference versus prior guidance is primarily attributable to certain capital expenditures having shifted from Q3 to Q4. There is no impact to full-year 2014 capital expenditure guidance, the company said.
07:49 EDTUALUnited Continental reports Q3 PRASM up 3.5%-4%
Subscribe for More Information
07:24 EDTUALUnited Continental added to U.S. Focus List at Credit Suisse
Subscribe for More Information
October 8, 2014
17:21 EDTUALUnited Continental reports September consolidated traffic down 0.2% y-o-y
Subscribe for More Information
13:00 EDTHSPHospira recalling one lot of Vancomycin Hydrochloride
The FDA announced that Hospira is initiating a voluntary nationwide user-level recall of one lot of Vancomycin Hydrochloride. The action is because the product may have experienced temperature excursions during shipment to a customer and then was further distributed by the customer, the agency said. It added that there have been no adverse events or complaints reported for the affected lot. Hospira is "undertaking the recall out of an abundance of caution," the FDA said.
11:26 EDTUALUnited Continental volatility increases as shares pull back
United Continental October weekly call option implied volatility is at 65, October is at 51, November is at 50, December is at 47; compared to its 26-week average of 43 according to Track Data, suggesting large price movement.
10:00 EDTMRVLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:42 EDTMRVLMarvell initiated with a Buy at Ladenburg
Subscribe for More Information
07:18 EDTDRTXInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use